Search Browse Earnings

HOOKIPA Pharma Inc. — SlamSEC

HOOKIPA Pharma Inc.

OTC:HOOK

Pharmaceutical Preparations·NEW YORK, NY

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$14.2M

-22.8% YoY

FY 2024

Adj. EBITDA

-$69.6M

-488.1% margin

FY 2024

Net Income

-$64.9M

-455.6% margin

FY 2024

EPS (Diluted)

-$9.91

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$117.1M

FY 2024

Total Debt

$1.2M

FY 2023

Net Cash

$115.9M

FY 2023

Enterprise Value

—

Debt / EBITDA

1.7x

FY 2024

EV / EBITDA

—

Employees

—